Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
about
IL-22 Protects against Tissue Damage during Cutaneous LeishmaniasisUltradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis AntigensA secondary wave of neutrophil infiltration causes necrosis and ulceration in lesions of experimental American cutaneous leishmaniasisInflammasomes in host response to protozoan parasites.Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathologyMapping the genes for susceptibility and response to Leishmania tropica in mousePKC/ROS-Mediated NLRP3 Inflammasome Activation Is Attenuated by Leishmania Zinc-Metalloprotease during Infection.CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.The Nlrp3 inflammasome, IL-1β, and neutrophil recruitment are required for susceptibility to a nonhealing strain of Leishmania major in C57BL/6 mice.Host genetic factors in American cutaneous leishmaniasis: a critical appraisal of studies conducted in an endemic area of Brazil.AIM2 inflammasome is associated with disease severity in tegumentary leishmaniasis caused by Leishmania (V.) braziliensis.Leishmania braziliensis amastigotes stimulate production of IL-1β, IL-6, IL-10 and TGF-β by peripheral blood mononuclear cells from nonendemic area healthy residents.Dectin-1 Activation during Leishmania amazonensis Phagocytosis Prompts Syk-Dependent Reactive Oxygen Species Production To Trigger Inflammasome Assembly and Restriction of Parasite Replication.Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation.Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis.IL-1β production by intermediate monocytes is associated with immunopathology in cutaneous leishmaniasis.
P2860
Q27301071-91F91862-12BD-4536-8B88-2B8B79E18404Q28550483-F2118AF5-F6BE-471A-8289-B68E003C99C7Q33773256-E84E9388-39C9-4315-961F-537F48EEFD85Q34043775-B51F4345-8ADD-40B8-9247-163681670DC9Q34717421-5C63870B-B9AD-4DA2-AC7C-C44A1999F318Q34855088-E4BA6A93-F578-4C97-ABC2-688EA849BE45Q35675399-C3FAAAE9-D16B-4371-AF0F-79C6D54826A6Q36278760-5C512931-4042-4AA4-B4C1-9585B30F09D6Q36788745-D083272E-04A5-4460-881C-467CCC1507E4Q38215168-616886C8-2CAC-4617-B42A-157BDA1A50D1Q38842848-F98724F5-24E3-4329-83D6-7AAEDCDFB4FEQ39027155-7925A688-E5D5-45A3-9B89-D906B527831FQ40103193-212EEDD1-8527-4641-9168-127E5E29F6C1Q40150240-D6564D8A-EC78-40C5-9BB2-D94DDDEF6139Q46080853-EF92145B-828F-40FC-A515-E2011153543CQ47287891-D585277B-C87E-406D-AFA1-5FC2EE6A81C7
P2860
Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
@ast
Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
@en
Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
@nl
type
label
Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
@ast
Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
@en
Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
@nl
prefLabel
Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
@ast
Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
@en
Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
@nl
P2093
P2860
P1476
Disease severity in patients infected with Leishmania mexicana relates to IL-1β.
@en
P2093
Claudia Rangel-Escareño
Edith A Fernández-Figueroa
Georgina Carrada-Figueroa
Ingeborg Becker
Karol Carrillo-Sánchez
Norma Salaiza-Suazo
Santiago March-Mifsut
Valeria Espinosa-Mateos
P2860
P356
10.1371/JOURNAL.PNTD.0001533
P407
P577
2012-05-22T00:00:00Z